Location: Stockbridge
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Stockbridge
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) Phase 3 · Phillip Nowlin · Harmony Biosciences Management, Inc. · NCT07500090 Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine Phase 3 · Sleep Care Research Institute d/b/a Clinical Research Atlant · Kallyope Inc. · NCT07674654 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Phase 2/Phase 3 · Piedmont Henry Hospital · NRG Oncology · NCT05174169 Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck) Phase N/A · Advanced Women's Care Center · Aspira Women's Health · NCT05245695 Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children Phase 2 · Sleep Care Research Institute d/b/a Clinical Research Instit · AbbVie · NCT03339128 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Phase 3 · Piedmont Henry Hospital · NRG Oncology · NCT03180268 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq Phase 3 · Piedmont Henry Hospital · NRG Oncology · NCT04852887 Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06568367 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin Phase 3 · Clinical Research Atlanta · Eli Lilly and Company · NCT07392190 A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy Phase 2 · Clinical Research Institute Stockbridge · Eisai Inc. · NCT07493265 A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults Phase 1 · GSK Investigational Site · GlaxoSmithKline · NCT07464314 A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Phase 3 · Institute of Endocrinology Diabetes, Health & Hormones- Site · Sanofi · NCT07088068 A Study to Learn About mRNA Vaccines Against Influenza in Adults Phase 2 · Clinical Research Atlanta · Pfizer · NCT07431853 A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia Phase 2 · Centessa Pharmaceuticals (UK) Limited · NCT07096674 A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia Phase 2 · Alkermes Investigator Site · Alkermes, Inc. · NCT06843590 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study Phase N/A · GA Interventional Pain-J, LLC · Stryker Instruments · NCT03072927 Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch Phase 3 · Sleep Care Research Institute d/b/a Clinical Research Instit · AbbVie · NCT05125302 A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia Phase 2/Phase 3 · Alkermes Investigational Site · Alkermes, Inc. · NCT06767683 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a Phase 3 · Research Site · AstraZeneca · NCT07000357 A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Ep Phase 3 · Sleep Care Research Institute d/b/a Clinical Research Instit · AbbVie · NCT04777357 A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Phase 3 · Clinical Research Atlanta · Pfizer · NCT06641466 A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) Phase 2 · Clinical Research Atlanta · Pfizer · NCT07575932 Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry) Phase N/A · Institute of Endocrinology Diabetes, Health & Hormones · DexCom, Inc. · NCT06483945 A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' D Phase 2 · Site Number - 1020 · Immunovant Sciences GmbH · NCT06727604 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Phase 3 · Piedmont Henry Hospital · NRG Oncology · NCT05879926 A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 Phase 3 · Alkermes Investigational Site · Alkermes, Inc. · NCT07502443 Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions. Phase 4 · Arthritis Research and Treatment Center · Primus Pharmaceuticals · NCT06157177 Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease Phase 2 · Research Site · AstraZeneca · NCT06824987 RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Th Phase N/A · Pain Care, LLC · Boston Scientific Corporation · NCT01719055
Look up another city
Look up another condition